RxDoctor Payments DataLook up a doctor →

Arturo Taca, MD

Psychiatry · Creve Coeur, MONPI 1295846319

Payments from drug & device makers

$257,799in general payments, 2019–2025

Across 725 payments — averaging $355.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$187K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$51K
  • MDD US Operations, LLC$10K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
  • Sunovion Pharmaceuticals Inc.$1K
  • AbbVie$983
  • plus $5K from 36 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alkermes, Inc.252$186,922
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)110$51,154
MDD US Operations, LLC28$10,434
Otsuka Pharmaceutical Development & Commercialization, Inc.4$2,183
Sunovion Pharmaceuticals Inc.46$1,399
AbbVie(2 entities)59$983
Otsuka America Pharmaceutical, Inc.46$713
Vanda Pharmaceuticals Inc.24$589
Neurocrine Biosciences, Inc.22$579
Teva Pharmaceuticals USA, Inc.16$443
E.r. Squibb & Sons, L.L.C.10$328
Neuronetics, Inc.6$299
Johnson & Johnson9$213
Lundbeck LLC10$185
Takeda Pharmaceuticals U.S.A., Inc.12$155
Validus Pharmaceuticals LLC10$132
Livanova USA, Inc.1$114
Ironshore Pharmaceuticals Inc.5$80
Avanir Pharmaceuticals, Inc.5$77
Bausch Health US, LLC4$71
Axsome Therapeutics, Inc.3$59
Masimo Corporation3$57
Shire North American Group Inc4$53
Adlon Therapeutics L.p.4$51
Indivior Inc.3$51
Supernus Pharmaceuticals, Inc.3$49
Corium, LLC2$48
Novo Nordisk3$45
Tempus AI, Inc2$38
Jazz Pharmaceuticals Inc.2$34
Nalpropion Pharmaceuticals LLC2$30
Amgen2$30
Tris Pharma Inc2$29
Almatica Pharma LLC2$29
Vertical Pharmaceuticals, LLC2$26
Hikma Pharmaceuticals USA1$21
Arbor Pharmaceuticals, Inc.1$19
Novartis1$19
Noven Therapeutics, LLC1$19
Braeburn Inc.1$15
Neos Therapeutics, LP1$14
Gilead1$12

How this compares

$257,799 in reported general payments places this provider in the 95th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri →

Medicare billing

Part B allowed, 2024
$142,947
Medicare patients
102
Services billed
1,239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Creve Coeur

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →